New Delhi : The Supreme Court on Tuesday agreed to examine the new national pharmaceutical pricing policy framed by the government for fixing prices of essential medicines in the country. 

A bench headed by Justice G S Singhvi asked the Centre to file its response on a petition challenging the policy and raised questions on prices of medicines fixed by govt.
“Margin of profit for manufacturers and dealers has become 10 per cent to 1300 per cent of the cost of manufacture of the drug,” the bench said after going through a data provided by the petitioner in the PIL.
The bench also pulled up the Centre for dilly dallying on the issue of price fixation for the last 10 years.

(For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Free Press Journal